Bringing The Next-Generation Of Antibiotics
to win the war against resistant bacteria
Omnix Medical is a biopharmaceutical company
Founded in 2015, Omnix Medical is developing an arsenal of novel antibiotic agents for the treatment of infections involving drug-resistant bacteria.
Omnix’s technology can tilt the odds in the battle against resistant bacteria and improve the lives of many people worldwide.
Our exceptional technology offers a first-in-its-class drug
Moving together towards a better future
MOVING TOGETHER TOWARDS A BETTER FUTURE
WE AT OMNIX MEDICAL
ARE ALWAYS LOOKING FOR EXTRAORDINARY PEOPLE TO JOIN OUR TEAM
New mechanism of action (MoA) addressing global increase of antimicrobial resistance (AMR) burden and shortage of potent anti-infectives JERUSALEM, Israel, April 12, 2022 — Omnix
Entirely novel therapeutic principle to combat alarming worldwide rise of antimicrobial resistance (AMR) JERUSALEM, Israel, March 16, 2022 — Omnix Medical, a biopharmaceutical company developing
To encourage EU Member States to actively contribute to exchanges on AMR in the co-legislative process, the BEAM Alliance relies on a network of National